Representative publications - Leukemia Cell Biology Group

  • Szánthó, H. P. Bhattoa, M. Csobán, P. Antal-Szalmás, A. Újfalusi, J. Kappelmayer, Z. Hevessy. Serum thymidine kinase activity: Analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia. PLOS ONE, 9(3):e91647, 2014 doi:10.1371/journal.pone.0091647
  • Eszter Szánthó, Bettina Kárai, Gergely Ivády, Judit Bedekovics, István Szegedi, Miklós Petrás, György Ujj, Anikó Ujfalusi, Csongor Kiss, János Kappelmayer, Zsuzsanna Hevessy. Comparative analysis of multicolour flow cytometry and immunohistochemistry for the detection of disseminated tumour cells. Appl Immunohistochem Mol Morphol, accepted for publication
  • Csáthy L, Kappelmayer J, Szegedi I, Kajtár B, Kiss C Hevessy Z. Classical and atypical Bedekovics J, Rejtő L, Telek B, Kiss A, Hevessy Zs, Újfalusi A, Méhes G. Identification of NPMc+ acute myeloid leukemia in bone marrow smears. Appl Immunohistochem Mol Morphol 2013, 21(1): 73-78
  • Simon Á, Bagoly Zs, Hevessy Zs, Csáthy L, Katona É, Vereb Gy, Ujfalusi A, Szerafin L, Muszbek L, Kappelmayer J. Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia. Cytometry B (Clinical Cytometry) 2012, 82B: 209-216
  • Hevessy Zs, Hudak R, Kiss-Sziraki V, Antal-Szalmas P, Udvardy M, Rejtő L,  Szerafin L, Kappelmayer J. Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay. Clin Chem Lab Med 2012, 50 (4): 689-692
  • Csáthy L, Kappelmayer J, Szegedi I, Kajtár B, Kiss C Hevessy Z. Classical and atypical neuroblastoma – case reports. Cytometry B (Clinical Cytometry) 2011, 80B: 134-136
  • Kiss F, Buslig J, Szegedi I, Scholtz B, Kappelmayer J, Kiss C. Early relapse after rituximab chemoimmunotherapy. Pediatr Blood Cancer 2008, 50: 372-5
  • Kiss F, Simon A, Csathy L, Hevessy Z, Katona E, Kiss C, Kappelmayer J. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII. Cytometry A 2008, 73: 194-201
  • Kiss F, Hevessy Z, Veszprémi A, Katona É, Vereb G, Kiss C, Muszbek L, Kappelmayer J. Leukemic lymphoblasts: a novel expression site for coagulation factor XIII subunit A. Thromb Haemost 2006,96: 176-182
  • Hevessy Z, Nagy B Jr, Kiss F, Kiss A, Kappelmayer J. Mean fluorescence intensity rate is a useful marker in the detection of paroxysmal nocturnal hemoglobinuria clones. Clin Chem Lab Med 2005, 43: 919-923
  • Kappelmayer J, Simon A, Katona E, Szanto A, Nagy L, Kiss A, Kiss C, Muszbek L. Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias. Thromb Haemost 2005, 94: 454-9
  • Kappelmayer J, Simon Á, Kiss F, Hevessy Z. Progress in defining multidrug resistance in leukemia. Exp Rev Mol Diagnos 2004, 2: 209-217
  • Karászi E, Jakab K, Homolya L, Szakács G, Holló Z, Telek B, Kiss A, Rejtő L, Nahajevszky S, Sarkadi B, Kappelmayer J. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukemia. Br J Haematol 2001, 112: 308-14
  • Kappelmayer J, Gratama JW, Karászi E, Menéndez P, Ciudad J, Rivas R, Orfao A. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols. J Immunol Methods 2000, 242: 53-65

Frissítés dátuma: 2019.06.05.